[HTML][HTML] Cardiac fibrosis: new insights into the pathogenesis

ZG Ma, YP Yuan, HM Wu, X Zhang… - International journal of …, 2018 - ncbi.nlm.nih.gov
Cardiac fibrosis is defined as the imbalance of extracellular matrix (ECM) production and
degradation, thus contributing to cardiac dysfunction in many cardiac pathophysiologic …

Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways

A Salminen, K Kaarniranta, A Kauppinen - Ageing research reviews, 2016 - Elsevier
AMP-activated protein kinase (AMPK) is a fundamental regulator of energy metabolism,
stress resistance, and cellular proteostasis. AMPK signaling controls an integrated signaling …

Activation and signaling by the AMP-activated protein kinase in endothelial cells

B Fisslthaler, I Fleming - Circulation research, 2009 - Am Heart Assoc
The AMP-activated protein kinase (AMPK) was initially identified as the kinase that
phosphorylates the 3-hydroxy 3-methylglutaryl coenzyme A reductase, the rate-limiting …

Obesity impairs skeletal muscle regeneration through inhibition of AMPK

X Fu, M Zhu, S Zhang, M Foretz, B Viollet, M Du - Diabetes, 2016 - Am Diabetes Assoc
Obesity is increasing rapidly worldwide and is accompanied by many complications,
including impaired muscle regeneration. The obese condition is known to inhibit AMPK …

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure

C Beauloye, L Bertrand, S Horman… - Cardiovascular …, 2011 - academic.oup.com
Heart failure is a progressive muscular disorder leading to a deterioration of the heart
characterized by a contractile dysfunction and a chronic energy deficit. As a consequence …

AMPK: A therapeutic target of heart failure—not only metabolism regulation

X Li, J Liu, Q Lu, D Ren, X Sun, T Rousselle… - Bioscience …, 2019 - portlandpress.com
Heart failure (HF) is a serious disease with high mortality. The incidence of this disease has
continued to increase over the past decade. All cardiovascular diseases causing dysfunction …

[HTML][HTML] GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK

D Aguilar-Recarte, E Barroso, A Guma… - Cell Reports, 2021 - cell.com
Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) activates AMP-activated protein
kinase (AMPK) and plays a crucial role in glucose and lipid metabolism. Here, we examine …

[HTML][HTML] IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells

AA Widjaja, S Viswanathan, JGW Ting, J Tan… - IScience, 2022 - cell.com
IL11 initiates fibroblast activation but also causes epithelial cell dysfunction. The
mechanisms underlying these processes are not known. We report that IL11-stimulated …

The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading …

E Barroso, R Rodríguez-Calvo, L Serrano-Marco… - …, 2011 - academic.oup.com
Metabolic syndrome-associated dyslipidemia is mainly initiated by hepatic overproduction of
the plasma lipoproteins carrying triglycerides. Here we examined the effects of the …

[HTML][HTML] Molecular dissection of pro-fibrotic IL11 signaling in cardiac and pulmonary fibroblasts

AA Widjaja, S Viswanathan, D Jinrui… - Frontiers in Molecular …, 2021 - frontiersin.org
In fibroblasts, TGFβ1 stimulates IL11 upregulation that leads to an autocrine loop of IL11-
dependent pro-fibrotic protein translation. The signaling pathways downstream of IL11 …